Therefore, one can expect pathological alterations that reflect the functioning of immunosuppressive mechanisms triggered by expansion of CD4 Treg population would also be detectable in the peripheral circulation during early stages of cervical cancer progression. The gene discussed is CD4; the disease is cervical carcinoma.